NCT03470740

Brief Summary

Rheumatoid arthritis (RA) is a persistent systemic disease. WHO (World Health Organization) commented that a crucial goal of heath care for RA is prevention of loss of daily function by patients' self-management (SM) skills; however, a comprehensive rheumatoid arthritis self-management (RASm) for RA patients' day-to-day self-managing is limited in Taiwan. Aims: The aims of the study are: (1) to implement the RASm program, (2) to determine the effectiveness of the program with 6 months follow-up, and (3) to understand participants' experiences when receiving the RASm program for the experimental group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
224

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

March 8, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 20, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2018

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

August 28, 2019

Completed
Last Updated

August 22, 2025

Status Verified

March 1, 2018

Enrollment Period

1.9 years

First QC Date

March 8, 2018

Results QC Date

November 21, 2018

Last Update Submit

August 4, 2025

Conditions

Keywords

rheumatoid arthritis, self-management, self-efficacy

Outcome Measures

Primary Outcomes (1)

  • Disease Activity

    Disease activity was measured using the DAS-28 (Disease Activity Score-28) which evaluated 28 tender and swollen joint counts of rheumatoid arthritis patients. This scale was used to calculate the 28 tender and swollen joint counts. Scores can range from 0 to 9.4. The lower score represent a better RA outcome.

    6 months

Secondary Outcomes (6)

  • Arthritis Self-efficacy- Pain

    6 months

  • Arthritis Self-efficacy- Other

    6 months

  • SF-36 Quality of life_Physical Component Scores

    6 months

  • Physical Functioning

    6 months

  • Self-management Behaviors

    6 months

  • +1 more secondary outcomes

Study Arms (2)

intervention group

OTHER

An individualized rheumatoid arthritis self-management program for managing RA patients' physical behavioral problems was applied for the intervention group. The program was based on the self-efficacy theory and the four resources were incorporated to emphasize patients' knowledge, skill, and responsibility in managing their RA situations.

Behavioral: rheumatoid arthritis self-management program

control group

NO INTERVENTION

The control group received general information on rheumatoid arthritis care and follow-up.

Interventions

The intervention group received the rheumatoid arthritis self-management program which was based on Bandura's theory of self-efficacy and proposes that self-efficacy is influenced by four information sources: mastery of experience, social modeling, social persuasion and one's physical and emotional states. To enhance participants' self-management skill, the following strategies were employed: peer story-telling, assessment, family involvement, goal setting, self-monitoring, self-evaluation, and phone calls consultation.

intervention group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with RA
  • Age of 20 years or over
  • Disease considered have been stable for at least 3 months
  • Able to understand and comply with the study treatment

You may not qualify if:

  • Suffering from other terminal illnesses, severe dementia or another debilitating psychiatric disorder
  • Living in a long-term care facility
  • Participation in another research protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Taoyuan District, 33303, Taiwan

Location

MeSH Terms

Conditions

Arthritis, Rheumatoid

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Results Point of Contact

Title
Su-Hui Chen
Organization
Chang Gung University of Science and Technology

Study Officials

  • Su-Hui Chen, PhD

    Professor, School of Nursing, Chang Gung University of Science and Technology

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The researcher who collected the data and the researcher who applied the intervention program was never the same.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned to experimental group who received a rheumatoid arthritis self-management intervention based on self-efficacy theory for 6 weeks, and a control group receiving standard rheumatology care only.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 8, 2018

First Posted

March 20, 2018

Study Start

September 1, 2016

Primary Completion

July 31, 2018

Study Completion

July 31, 2018

Last Updated

August 22, 2025

Results First Posted

August 28, 2019

Record last verified: 2018-03

Locations